Polyene Antifungal [EPC]

Polyene Antifungal [EPC] was reported 40450 times

Drugs of the Polyene Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SALPINGO-OOPHORECTOMY UNILATERAL 48 0.4364
1 TOTAL LUNG CAPACITY INCREASED 97 0.3566
2 DISSEMINATED MUCORMYCOSIS 79 0.2005
3 CHOROIDITIS 72 0.1925
4 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 97 0.1855
5 FUNGAL ENDOCARDITIS 46 0.1528
6 CEREBRAL ASPERGILLOSIS 87 0.1415
7 FUSARIUM INFECTION 99 0.1414
8 RHINOCEREBRAL MUCORMYCOSIS 49 0.1412
9 PULMONARY MUCORMYCOSIS 69 0.1307
10 TRICHOSPORON INFECTION 50 0.1235
11 MUCORMYCOSIS 315 0.1211
12 SCEDOSPORIUM INFECTION 79 0.1119
13 DISSEMINATED ASPERGILLOSIS 49 0.1038
14 SINUSITIS FUNGAL 78 0.0973
15 EYE INFECTION FUNGAL 35 0.0904
16 DISSEMINATED CRYPTOCOCCOSIS 68 0.0898
17 MENINGITIS CRYPTOCOCCAL 155 0.0886
18 CRYPTOCOCCOSIS 130 0.0797
19 FUNGAEMIA 118 0.0749
20 ASPERGILLOSIS 88 0.0673
21 DELAYED GRAFT FUNCTION 46 0.0647
22 ASPERGILLUS INFECTION 425 0.0647
23 VISCERAL LEISHMANIASIS 45 0.0623
24 SYSTEMIC MYCOSIS 71 0.0608
25 RECTAL PROLAPSE 63 0.0522
26 SYSTEMIC CANDIDA 130 0.0517
27 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 54 0.0508
28 JAUNDICE CHOLESTATIC 179 0.0506
29 HYPOMANIA 182 0.0494
30 CANDIDA SEPSIS 44 0.0491
31 SEPTIC EMBOLUS 40 0.0481
32 BRONCHOPULMONARY ASPERGILLOSIS 354 0.0456
33 HYPERPARATHYROIDISM SECONDARY 114 0.0455
34 IMMUNE RECONSTITUTION SYNDROME 58 0.0449
35 NEPHROGENIC ANAEMIA 200 0.0431
36 CANDIDA INFECTION 724 0.0428
37 INTERVERTEBRAL DISC SPACE NARROWING 34 0.0422
38 COMPLICATIONS OF TRANSPLANTED KIDNEY 94 0.0414
39 PNEUMONIA CRYPTOCOCCAL 39 0.0413
40 HISTOPLASMOSIS DISSEMINATED 65 0.0409
41 PSEUDOMONAL BACTERAEMIA 34 0.0398
42 FEMALE GENITAL TRACT FISTULA 67 0.0392
43 CAROTID ARTERIOSCLEROSIS 40 0.0388
44 URINARY TRACT INFECTION ENTEROCOCCAL 36 0.0385
45 ORAL CANDIDIASIS 500 0.0379
46 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 180 0.0361
47 PNEUMONIA FUNGAL 140 0.0355
48 RENAL ARTERY STENOSIS 48 0.0348
49 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 73 0.0343
50 ENTEROCOCCAL INFECTION 165 0.0341
51 AORTIC DILATATION 37 0.0333
52 SPUTUM INCREASED 69 0.0319
53 NASAL POLYPS 154 0.0312
54 CANDIDIASIS 124 0.0309
55 RHINITIS ALLERGIC 137 0.0307
56 KYPHOSIS 53 0.0300
57 BK VIRUS INFECTION 100 0.0296
58 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 69 0.0294
59 PNEUMONIA PSEUDOMONAL 44 0.0287
60 HISTOPLASMOSIS 50 0.0282
61 KLEBSIELLA INFECTION 141 0.0279
62 FUNGAL SKIN INFECTION 112 0.0277
63 BRAIN ABSCESS 70 0.0276
64 PARAINFLUENZAE VIRUS INFECTION 42 0.0276
65 STENOTROPHOMONAS INFECTION 37 0.0273
66 HEPATOSPLENOMEGALY 69 0.0269
67 PSEUDOMONAL SEPSIS 47 0.0268
68 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 72 0.0260
69 ORAL FUNGAL INFECTION 71 0.0259
70 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 85 0.0257
71 CYTOMEGALOVIRUS TEST POSITIVE 45 0.0252
72 SARCOIDOSIS 115 0.0242
73 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 34 0.0241
74 CHRONIC SINUSITIS 90 0.0240
75 ENTEROBACTER INFECTION 40 0.0238
76 AORTIC ARTERIOSCLEROSIS 59 0.0229
77 DIASTOLIC DYSFUNCTION 70 0.0227
78 PSEUDOMONAS INFECTION 193 0.0225
79 TRANSPLANT REJECTION 178 0.0222
80 TONGUE ULCERATION 75 0.0222
81 RESPIRATORY SYMPTOM 61 0.0214
82 GRAFT VERSUS HOST DISEASE 154 0.0214
83 ENDOPHTHALMITIS 128 0.0213
84 NEPHROPATHY TOXIC 239 0.0213
85 STAPHYLOCOCCAL BACTERAEMIA 92 0.0211
86 LOBAR PNEUMONIA 39 0.0210
87 OESOPHAGEAL CANDIDIASIS 83 0.0208
88 REBOUND ACID HYPERSECRETION 63 0.0208
89 SCHIZOPHRENIA 251 0.0206
90 HYPOPROTEINAEMIA 39 0.0205
91 BRAIN HERNIATION 61 0.0204
92 PNEUMONIA KLEBSIELLA 37 0.0201
93 ACTINIC KERATOSIS 52 0.0200
94 KIDNEY TRANSPLANT REJECTION 95 0.0198
95 TOXIC EPIDERMAL NECROLYSIS 298 0.0196
96 BRONCHIECTASIS 131 0.0194
97 BLOOD CULTURE POSITIVE 58 0.0194
98 ESSENTIAL HYPERTENSION 35 0.0191
99 GRANULOMA 66 0.0190
100 APLASTIC ANAEMIA 98 0.0187
101 MULTIPLE ORGAN DYSFUNCTION SYNDROME 529 0.0187
102 NEUTROPENIC COLITIS 38 0.0184
103 FAILURE TO THRIVE 95 0.0183
104 RHINOVIRUS INFECTION 71 0.0182
105 FUNGAL INFECTION 594 0.0178
106 BACTERIAL SEPSIS 58 0.0178
107 LEFT VENTRICULAR HYPERTROPHY 76 0.0177
108 ODYNOPHAGIA 105 0.0176
109 EMBOLISM VENOUS 53 0.0175
110 ESCHERICHIA BACTERAEMIA 40 0.0170
111 CARDIAC MURMUR 147 0.0170
112 FEBRILE NEUTROPENIA 1125 0.0169
113 PATHOGEN RESISTANCE 154 0.0169
114 VARICELLA ZOSTER VIRUS INFECTION 35 0.0169
115 CYTOMEGALOVIRUS INFECTION 280 0.0168
116 OTITIS MEDIA 54 0.0163
117 GRAFT VERSUS HOST DISEASE IN SKIN 36 0.0163
118 CLOSTRIDIUM TEST POSITIVE 36 0.0163
119 END STAGE RENAL DISEASE 294 0.0161
120 NOCARDIOSIS 41 0.0160
121 VENOOCCLUSIVE DISEASE 40 0.0160
122 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 61 0.0160
123 STAPHYLOCOCCAL SEPSIS 78 0.0158
124 CHRONIC GRAFT VERSUS HOST DISEASE 57 0.0158
125 MUCOSAL INFLAMMATION 412 0.0157
126 RENAL TUBULAR NECROSIS 154 0.0157
127 TRICUSPID VALVE INCOMPETENCE 124 0.0156
128 TRANSPLANT FAILURE 38 0.0155
129 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 114 0.0152
130 DRUG RESISTANCE 388 0.0151
131 SEPTIC SHOCK 651 0.0149
132 CYTOMEGALOVIRUS VIRAEMIA 66 0.0148
133 ADENOVIRUS INFECTION 43 0.0148
134 OLIGURIA 92 0.0148
135 MEAN CELL VOLUME INCREASED 38 0.0148
136 LUNG INFILTRATION 130 0.0147
137 NEUTROPENIC SEPSIS 105 0.0147
138 NEUROLOGICAL DECOMPENSATION 34 0.0147
139 DRUG LEVEL BELOW THERAPEUTIC 81 0.0147
140 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 39 0.0147
141 ESCHERICHIA INFECTION 120 0.0146
142 VENOOCCLUSIVE LIVER DISEASE 72 0.0146
143 INTRACRANIAL PRESSURE INCREASED 80 0.0143
144 ESCHERICHIA URINARY TRACT INFECTION 61 0.0143
145 HEPATOTOXICITY 318 0.0143
146 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 135 0.0141
147 HIATUS HERNIA 182 0.0140
148 HAEMATOLOGICAL INFECTION 34 0.0139
149 CYSTITIS HAEMORRHAGIC 56 0.0139
150 RENAL TUBULAR DISORDER 39 0.0138
151 DIVERTICULUM 98 0.0138
152 CYTOMEGALOVIRUS INFECTION REACTIVATION 60 0.0136
153 ATELECTASIS 130 0.0134
154 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 67 0.0132
155 LUNG CONSOLIDATION 37 0.0132
156 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 67 0.0132
157 SPINAL OSTEOARTHRITIS 113 0.0128
158 HYDRONEPHROSIS 96 0.0128
159 BACTERAEMIA 152 0.0128
160 DIVERTICULUM INTESTINAL 56 0.0128
161 NECROSIS 71 0.0127
162 BUNDLE BRANCH BLOCK LEFT 54 0.0127
163 CLOSTRIDIUM DIFFICILE COLITIS 133 0.0125
164 BLOOD BILIRUBIN INCREASED 338 0.0125
165 CHRONIC KIDNEY DISEASE 942 0.0124
166 BLOOD ALBUMIN DECREASED 98 0.0123
167 HYDROCEPHALUS 66 0.0121
168 VASCULAR DEVICE INFECTION 54 0.0119
169 HERPES SIMPLEX 77 0.0118
170 ACUTE RESPIRATORY FAILURE 227 0.0118
171 PULMONARY HAEMORRHAGE 92 0.0117
172 LUNG NEOPLASM 50 0.0117
173 HYPERCAPNIA 35 0.0116
174 MULTIPLE-DRUG RESISTANCE 36 0.0116
175 OBSTRUCTIVE AIRWAYS DISORDER 129 0.0116
176 PATENT DUCTUS ARTERIOSUS 46 0.0116
177 HYPERBILIRUBINAEMIA 120 0.0116
178 ACUTE GRAFT VERSUS HOST DISEASE 53 0.0116
179 ELECTROLYTE IMBALANCE 134 0.0115
180 INFLAMMATORY MARKER INCREASED 57 0.0115
181 ISCHAEMIC CARDIOMYOPATHY 35 0.0114
182 LIVER ABSCESS 37 0.0114
183 HYPOKALAEMIA 526 0.0114
184 IRON DEFICIENCY ANAEMIA 105 0.0114
185 ORTHOSTATIC HYPOTENSION 196 0.0112
186 ORAL DISORDER 82 0.0112
187 BLOOD CREATININE DECREASED 35 0.0112
188 BENIGN PROSTATIC HYPERPLASIA 57 0.0110
189 CHOLELITHIASIS 357 0.0109
190 ENCEPHALITIS 75 0.0108
191 RESPIRATORY FAILURE 782 0.0107
192 UROSEPSIS 98 0.0106
193 AORTIC VALVE INCOMPETENCE 45 0.0106
194 SEPSIS 1173 0.0105
195 MULTI-ORGAN FAILURE 179 0.0103
196 CAROTID ARTERY STENOSIS 36 0.0103
197 MOUTH ULCERATION 217 0.0103
198 SQUAMOUS CELL CARCINOMA OF SKIN 62 0.0103
199 AZOTAEMIA 41 0.0103
200 BRAIN OEDEMA 127 0.0100
201 SPINAL STENOSIS 41 0.0099
202 PANCYTOPENIA 552 0.0099
203 DISSEMINATED INTRAVASCULAR COAGULATION 139 0.0099
204 OESOPHAGITIS 107 0.0098
205 ECONOMIC PROBLEM 145 0.0096
206 BREATH SOUNDS ABNORMAL 47 0.0095
207 EMPHYSEMA 96 0.0095
208 DRUG LEVEL ABOVE THERAPEUTIC 43 0.0094
209 ACUTE KIDNEY INJURY 1436 0.0094
210 DECUBITUS ULCER 76 0.0093
211 DRUG LEVEL INCREASED 154 0.0093
212 PNEUMONIA BACTERIAL 85 0.0093
213 HEPATIC LESION 40 0.0092
214 LEUKOPENIA 462 0.0092
215 MITRAL VALVE INCOMPETENCE 104 0.0092
216 PULSELESS ELECTRICAL ACTIVITY 38 0.0091
217 SKIN INFECTION 101 0.0090
218 PULMONARY MASS 134 0.0090
219 TACHYPNOEA 122 0.0090
220 ORAL INFECTION 35 0.0089
221 RENAL CYST 71 0.0089
222 ENCEPHALOPATHY 219 0.0089
223 SLEEP APNOEA SYNDROME 170 0.0089
224 STEVENS-JOHNSON SYNDROME 198 0.0089
225 HYPERVOLAEMIA 44 0.0089
226 HYPOALBUMINAEMIA 69 0.0089
227 HYPOGAMMAGLOBULINAEMIA 58 0.0088
228 TOOTH INFECTION 116 0.0088
229 STAPHYLOCOCCAL INFECTION 289 0.0088
230 ORAL PAIN 196 0.0087
231 HYPOVOLAEMIA 51 0.0087
232 GINGIVITIS 47 0.0087
233 EPSTEIN-BARR VIRUS INFECTION 54 0.0086
234 RENAL FAILURE 1147 0.0086
235 HYPOXIA 304 0.0086
236 HYPERURICAEMIA 35 0.0085
237 ACUTE RESPIRATORY DISTRESS SYNDROME 150 0.0085
238 HYPOMAGNESAEMIA 118 0.0085
239 PNEUMOCYSTIS JIROVECII PNEUMONIA 85 0.0085
240 CARDIOMEGALY 104 0.0084
241 PNEUMOTHORAX 134 0.0084
242 INTERVERTEBRAL DISC DEGENERATION 78 0.0084
243 MENTAL STATUS CHANGES 234 0.0084
244 SUSPECTED OFF LABEL USE 38 0.0084
245 HAEMODYNAMIC INSTABILITY 64 0.0084
246 ENDOCARDITIS 43 0.0084
247 PLEURAL EFFUSION 505 0.0083
248 SKIN NECROSIS 43 0.0083
249 RENAL FAILURE ACUTE 351 0.0083
250 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 45 0.0083
251 TONGUE DISCOLOURATION 36 0.0082
252 HYPERNATRAEMIA 41 0.0082
253 TRANSFUSION 86 0.0082
254 PURULENT DISCHARGE 35 0.0082
255 TUBULOINTERSTITIAL NEPHRITIS 153 0.0082
256 GENERALISED OEDEMA 101 0.0082
257 HAEMOLYTIC ANAEMIA 73 0.0081
258 BACTERIAL INFECTION 152 0.0081
259 CHEILITIS 44 0.0081
260 SPLENOMEGALY 95 0.0081
261 DIABETIC NEUROPATHY 40 0.0081
262 RESPIRATORY DISTRESS 222 0.0080
263 SKIN ABRASION 38 0.0080
264 CYTOKINE RELEASE SYNDROME 161 0.0080
265 HYPOVOLAEMIC SHOCK 38 0.0079
266 STREPTOCOCCAL INFECTION 44 0.0079
267 APHTHOUS ULCER 61 0.0079
268 DRUG LEVEL DECREASED 80 0.0079
269 ISCHAEMIA 36 0.0078
270 RESPIRATORY SYNCYTIAL VIRUS INFECTION 68 0.0078
271 MENINGITIS 52 0.0078
272 URINE OUTPUT DECREASED 68 0.0078
273 STOMATITIS 467 0.0077
274 PRE-EXISTING CONDITION IMPROVED 48 0.0077
275 PULMONARY CONGESTION 101 0.0077
276 UPPER-AIRWAY COUGH SYNDROME 63 0.0076
277 ILEUS 95 0.0076
278 IMPAIRED GASTRIC EMPTYING 104 0.0076
279 BUNDLE BRANCH BLOCK RIGHT 35 0.0076
280 ENTEROCOLITIS 44 0.0076
281 SHOCK HAEMORRHAGIC 62 0.0076
282 HAEMATOCRIT DECREASED 151 0.0076
283 BLOOD UREA INCREASED 127 0.0076
284 ABSCESS 121 0.0076
285 CACHEXIA 39 0.0076
286 POSTOPERATIVE WOUND INFECTION 51 0.0075
287 PERIPHERAL SENSORY NEUROPATHY 44 0.0075
288 CELLULITIS 378 0.0075
289 VITAMIN D DEFICIENCY 73 0.0075
290 BONE MARROW FAILURE 151 0.0074
291 FLUID OVERLOAD 108 0.0074
292 SUPRAVENTRICULAR TACHYCARDIA 71 0.0074
293 RENAL INJURY 220 0.0074
294 BLOOD CREATININE INCREASED 483 0.0074
295 DERMATITIS EXFOLIATIVE 37 0.0074
296 HYSTERECTOMY 64 0.0074
297 DEVICE RELATED INFECTION 113 0.0073
298 MALNUTRITION 82 0.0073
299 PNEUMONITIS 199 0.0073
300 SPINAL COMPRESSION FRACTURE 60 0.0072
301 ANHEDONIA 190 0.0072
302 HYPERLIPIDAEMIA 85 0.0071
303 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 371 0.0071
304 PULMONARY HYPERTENSION 148 0.0071
305 PSYCHOTIC DISORDER 209 0.0071
306 RALES 41 0.0071
307 OSTEOPENIA 107 0.0070
308 RENAL IMPAIRMENT 592 0.0070
309 HAEMODIALYSIS 59 0.0070
310 RENAL FAILURE CHRONIC 54 0.0070
311 LEFT VENTRICULAR DYSFUNCTION 47 0.0070
312 INFUSION SITE SWELLING 44 0.0070
313 CENTRAL NERVOUS SYSTEM LESION 96 0.0070
314 THROMBOCYTOPENIA 781 0.0070
315 COAGULOPATHY 116 0.0070
316 HYPOPHOSPHATAEMIA 51 0.0069
317 PULMONARY OEDEMA 308 0.0069
318 NEUTROPENIA 929 0.0068
319 CEREBRAL ISCHAEMIA 35 0.0068
320 ARTERIOSCLEROSIS 64 0.0068
321 THROMBOTIC MICROANGIOPATHY 66 0.0068
322 HAEMORRHOIDS 132 0.0068
323 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 371 0.0068
324 LUNG INFECTION 105 0.0068
325 TORSADE DE POINTES 53 0.0067
326 SMALL INTESTINAL OBSTRUCTION 83 0.0067
327 CHOLECYSTITIS 80 0.0067
328 BLOOD POTASSIUM INCREASED 109 0.0067
329 GASTROOESOPHAGEAL REFLUX DISEASE 539 0.0067
330 PROTHROMBIN TIME PROLONGED 40 0.0067
331 BLOOD ALKALINE PHOSPHATASE INCREASED 166 0.0067
332 HYPERTRANSAMINASAEMIA 46 0.0066
333 OSTEOMYELITIS 119 0.0066
334 HEMIPARESIS 111 0.0065
335 HEPATOMEGALY 64 0.0065
336 GASTROENTERITIS 95 0.0065
337 FLANK PAIN 61 0.0065
338 UVEITIS 88 0.0065
339 PNEUMONIA 2099 0.0065
340 SINUS TACHYCARDIA 92 0.0065
341 BLOOD TEST ABNORMAL 91 0.0065
342 HYPERKALAEMIA 227 0.0065
343 IMMUNOSUPPRESSION 57 0.0065
344 HAEMOPTYSIS 180 0.0064
345 DYSPNOEA EXERTIONAL 243 0.0064
346 PHARYNGITIS 80 0.0064
347 OSTEOPOROSIS 265 0.0064
348 SKIN MASS 43 0.0064
349 COVID-19 PNEUMONIA 76 0.0064
350 WHEEZING 381 0.0064
351 SKIN ULCER 166 0.0064
352 C-REACTIVE PROTEIN INCREASED 233 0.0064
353 ACUTE MYELOID LEUKAEMIA 99 0.0063
354 LARGE INTESTINE POLYP 44 0.0063
355 PYELONEPHRITIS 55 0.0063
356 ADRENAL INSUFFICIENCY 77 0.0063
357 BLOOD POTASSIUM DECREASED 190 0.0063
358 ASCITES 185 0.0063
359 OEDEMA PERIPHERAL 767 0.0063
360 SHOCK 144 0.0063
361 BLOOD MAGNESIUM DECREASED 54 0.0063
362 PLEURISY 37 0.0062
363 OSTEOARTHRITIS 264 0.0062
364 RASH MACULO-PAPULAR 138 0.0062
365 HOSPICE CARE 61 0.0062
366 SQUAMOUS CELL CARCINOMA 58 0.0062
367 ACIDOSIS 47 0.0061
368 BODY TEMPERATURE INCREASED 125 0.0061
369 UPPER GASTROINTESTINAL HAEMORRHAGE 103 0.0061
370 PRODUCTIVE COUGH 292 0.0061
371 LYMPHOEDEMA 42 0.0061
372 IMMUNODEFICIENCY 90 0.0060
373 NEUROTOXICITY 105 0.0060
374 LYMPHOPENIA 84 0.0059
375 CARDIOGENIC SHOCK 85 0.0059
376 RESPIRATORY DISORDER 177 0.0059
377 MULTIPLE INJURIES 37 0.0059
378 HYPONATRAEMIA 330 0.0059
379 WOUND INFECTION 64 0.0058
380 ECCHYMOSIS 40 0.0058
381 SKIN LESION 160 0.0058
382 LEUKOCYTOSIS 105 0.0058
383 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 45 0.0058
384 LYMPHADENOPATHY 205 0.0058
385 METABOLIC ACIDOSIS 185 0.0058
386 THERAPY NON-RESPONDER 260 0.0058
387 EMBOLISM 48 0.0058
388 PNEUMONIA ASPIRATION 144 0.0058
389 MULTIPLE ALLERGIES 45 0.0057
390 URINARY TRACT INFECTION 973 0.0057
391 ANAEMIA 1087 0.0057
392 VENTRICULAR TACHYCARDIA 94 0.0057
393 MYOPATHY 49 0.0057
394 VENTRICULAR FIBRILLATION 63 0.0057
395 PREMATURE DELIVERY 90 0.0056
396 DISEASE PROGRESSION 667 0.0056
397 DYSPHAGIA 535 0.0056
398 INFUSION SITE EXTRAVASATION 35 0.0056
399 RESPIRATORY TRACT INFECTION 146 0.0056
400 GAMMA-GLUTAMYLTRANSFERASE INCREASED 124 0.0056
401 ARTERIOSCLEROSIS CORONARY ARTERY 37 0.0056
402 HEPATIC ENZYME INCREASED 380 0.0056
403 BLOOD SODIUM DECREASED 105 0.0056
404 CARDIOMYOPATHY 82 0.0055
405 LOWER GASTROINTESTINAL HAEMORRHAGE 41 0.0055
406 UPPER RESPIRATORY TRACT INFECTION 256 0.0055
407 RED BLOOD CELL COUNT DECREASED 158 0.0055
408 DENTAL CARIES 61 0.0055
409 HYPERCALCAEMIA 68 0.0055
410 BLOOD LACTATE DEHYDROGENASE INCREASED 87 0.0055
411 PYREXIA 1894 0.0055
412 TENDERNESS 57 0.0055
413 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 45 0.0055
414 INFUSION SITE ERYTHEMA 46 0.0055
415 HEPATIC FAILURE 164 0.0054
416 SINUSITIS 555 0.0054
417 ATRIAL FIBRILLATION 526 0.0054
418 INTRAOCULAR PRESSURE INCREASED 69 0.0054
419 HYPOPHAGIA 138 0.0054
420 CYTOPENIA 66 0.0054
421 SEASONAL ALLERGY 76 0.0054
422 NEPHROPATHY 50 0.0053
423 HEPATIC STEATOSIS 99 0.0053
424 ELECTROCARDIOGRAM QT PROLONGED 191 0.0053
425 GASTRITIS 139 0.0053
426 PERICARDIAL EFFUSION 121 0.0052
427 DEHYDRATION 697 0.0052
428 CHOLESTASIS 100 0.0052
429 CLOSTRIDIUM DIFFICILE INFECTION 113 0.0052
430 HEPATIC CYTOLYSIS 66 0.0052
431 TOOTH FRACTURE 57 0.0052
432 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 53 0.0052
433 GINGIVAL PAIN 41 0.0051
434 GASTROENTERITIS VIRAL 93 0.0051
435 ROTATOR CUFF SYNDROME 66 0.0051
436 OXYGEN SATURATION DECREASED 288 0.0051
437 CONJUNCTIVITIS 95 0.0051
438 ANURIA 44 0.0051
439 ORAL DISCOMFORT 71 0.0051
440 ELECTROCARDIOGRAM ABNORMAL 40 0.0051
441 LIVER FUNCTION TEST ABNORMAL 148 0.0051
442 RESTLESS LEGS SYNDROME 92 0.0051
443 CONDITION AGGRAVATED 1538 0.0051
444 CIRCULATORY COLLAPSE 86 0.0050
445 IMMUNE SYSTEM DISORDER 66 0.0050
446 MUSCULOSKELETAL CHEST PAIN 77 0.0050
447 FOLLICULITIS 52 0.0050
448 ALANINE AMINOTRANSFERASE INCREASED 304 0.0049
449 CARPAL TUNNEL SYNDROME 69 0.0049
450 LYMPHOCYTE COUNT DECREASED 87 0.0049
451 MYOCARDITIS 56 0.0049
452 HYPERGLYCAEMIA 178 0.0049
453 NEUTROPHIL COUNT INCREASED 50 0.0049
454 GLOMERULAR FILTRATION RATE DECREASED 60 0.0049
455 DRUG-INDUCED LIVER INJURY 153 0.0049
456 DIALYSIS 69 0.0049
457 HYPOCALCAEMIA 92 0.0049
458 GOUT 87 0.0048
459 OEDEMA 262 0.0048
460 PAPULE 34 0.0048
461 DIFFUSE LARGE B-CELL LYMPHOMA 37 0.0048
462 HAEMOGLOBIN DECREASED 492 0.0048
463 COLITIS 181 0.0048
464 INFECTION 690 0.0048
465 BREAST CANCER METASTATIC 51 0.0047
466 SPUTUM DISCOLOURED 45 0.0047
467 DECREASED ACTIVITY 51 0.0047
468 ASPARTATE AMINOTRANSFERASE INCREASED 251 0.0047
469 BLOOD CALCIUM DECREASED 53 0.0047
470 ORAL HERPES 92 0.0047
471 GLOSSODYNIA 105 0.0047
472 CYSTITIS 149 0.0047
473 RIB FRACTURE 96 0.0047
474 MOUTH HAEMORRHAGE 34 0.0046
475 DRUG TOXICITY 63 0.0046
476 PHARYNGITIS STREPTOCOCCAL 50 0.0046
477 DEEP VEIN THROMBOSIS 300 0.0046
478 ERYTHEMA MULTIFORME 43 0.0046
479 PETECHIAE 48 0.0046
480 EXOSTOSIS 42 0.0046
481 PHARYNGEAL SWELLING 45 0.0046
482 OBESITY 73 0.0046
483 SECRETION DISCHARGE 57 0.0045
484 TRANSAMINASES INCREASED 101 0.0045
485 INCONTINENCE 48 0.0045
486 VIRAL INFECTION 151 0.0045
487 DRUG INTERACTION 719 0.0045
488 TOOTHACHE 82 0.0045
489 BRONCHITIS 335 0.0045
490 DELIRIUM 156 0.0045
491 BASAL CELL CARCINOMA 70 0.0045
492 HAEMATOMA 116 0.0045
493 HAEMATURIA 153 0.0045
494 RHINITIS 36 0.0045
495 TASTE DISORDER 90 0.0044
496 TUMOUR LYSIS SYNDROME 39 0.0044
497 SKIN LACERATION 48 0.0044
498 GENERAL PHYSICAL HEALTH DETERIORATION 510 0.0044
499 ATAXIA 52 0.0044
500 BLOOD PRESSURE FLUCTUATION 105 0.0044
501 FACIAL PAIN 39 0.0044
502 PROTEINURIA 83 0.0044
503 HYPOTENSION 874 0.0044
504 URINARY INCONTINENCE 129 0.0043
505 GASTROINTESTINAL INFECTION 39 0.0043
506 LIGAMENT SPRAIN 43 0.0043
507 CARDIAC FAILURE CONGESTIVE 349 0.0043
508 MUSCLE ATROPHY 55 0.0043
509 HAEMATEMESIS 110 0.0043
510 BONE DISORDER 79 0.0043
511 BLADDER DISORDER 43 0.0043
512 VITAMIN D DECREASED 37 0.0043
513 HEMIPLEGIA 36 0.0043
514 MASS 60 0.0043
515 VASCULITIS 50 0.0043
516 DISEASE RECURRENCE 204 0.0043
517 PSYCHOLOGICAL TRAUMA 37 0.0043
518 EAR INFECTION 114 0.0043
519 NEURALGIA 104 0.0043
520 CARDIAC ARREST 353 0.0043
521 TACHYCARDIA 376 0.0042
522 PULMONARY EMBOLISM 402 0.0042
523 TOOTH ABSCESS 43 0.0042
524 RESPIRATORY TRACT CONGESTION 67 0.0042
525 CEREBRAL INFARCTION 103 0.0042
526 SALIVARY HYPERSECRETION 42 0.0042
527 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 37 0.0042
528 EJECTION FRACTION DECREASED 65 0.0042
529 HYPERTHYROIDISM 60 0.0041
530 SUBDURAL HAEMATOMA 59 0.0041
531 EAR PAIN 80 0.0041
532 GENERALISED TONIC-CLONIC SEIZURE 68 0.0041
533 UNRESPONSIVE TO STIMULI 106 0.0041
534 NO THERAPEUTIC RESPONSE 50 0.0041
535 EYE PAIN 231 0.0041
536 WHITE BLOOD CELL COUNT INCREASED 157 0.0041
537 LETHARGY 235 0.0041
538 HAEMORRHAGE INTRACRANIAL 61 0.0041
539 HERPES ZOSTER 234 0.0041
540 OROPHARYNGEAL PAIN 377 0.0041
541 SINUS CONGESTION 55 0.0041
542 GASTROINTESTINAL HAEMORRHAGE 339 0.0041
543 GASTRIC ULCER 77 0.0040
544 PLATELET COUNT DECREASED 430 0.0040
545 ASPIRATION 44 0.0040
546 ASTHMA 454 0.0040
547 BLISTER 225 0.0040
548 TREATMENT FAILURE 331 0.0040
549 AGRANULOCYTOSIS 74 0.0040
550 COUGH 1115 0.0040
551 HEPATIC ENCEPHALOPATHY 37 0.0040
552 FOOT FRACTURE 75 0.0040
553 HALLUCINATION, VISUAL 82 0.0039
554 INFUSION SITE PAIN 50 0.0039
555 PRODUCT USE IN UNAPPROVED INDICATION 961 0.0039
556 FULL BLOOD COUNT ABNORMAL 41 0.0039
557 METASTASES TO CENTRAL NERVOUS SYSTEM 50 0.0039
558 POST PROCEDURAL HAEMORRHAGE 45 0.0039
559 INSURANCE ISSUE 59 0.0039
560 DERMATITIS CONTACT 44 0.0039
561 DEFORMITY 36 0.0038
562 DYSPHONIA 225 0.0038
563 PLATELET COUNT INCREASED 50 0.0038
564 JAUNDICE 103 0.0038
565 LOWER RESPIRATORY TRACT INFECTION 174 0.0038
566 FISTULA 43 0.0038
567 LIVER FUNCTION TEST INCREASED 82 0.0038
568 PAIN IN JAW 108 0.0038
569 PRODUCT PRESCRIBING ISSUE 83 0.0038
570 NEUROPATHY PERIPHERAL 362 0.0038
571 INCREASED TENDENCY TO BRUISE 35 0.0038
572 TOOTH DISORDER 84 0.0038
573 KIDNEY INFECTION 74 0.0038
574 TENDONITIS 58 0.0037
575 SUBARACHNOID HAEMORRHAGE 38 0.0037
576 QUALITY OF LIFE DECREASED 50 0.0037
577 GASTROINTESTINAL PAIN 41 0.0037
578 DYSURIA 137 0.0037
579 BURSITIS 45 0.0037
580 FEEDING DISORDER 75 0.0037
581 GRAND MAL CONVULSION 34 0.0037
582 LIP SWELLING 122 0.0037
583 VOMITING 1722 0.0037
584 VENTRICULAR EXTRASYSTOLES 38 0.0037
585 PANCREATITIS ACUTE 82 0.0036
586 OSTEONECROSIS OF JAW 90 0.0036
587 HEPATITIS 93 0.0036
588 NEUTROPHIL COUNT DECREASED 148 0.0036
589 STATUS EPILEPTICUS 41 0.0036
590 NOCTURIA 44 0.0036
591 INFLAMMATION 187 0.0036
592 PRESYNCOPE 88 0.0036
593 IMPAIRED QUALITY OF LIFE 52 0.0036
594 DIVERTICULITIS 100 0.0036
595 POST PROCEDURAL COMPLICATION 69 0.0036
596 POLYNEUROPATHY 43 0.0036
597 INTERNATIONAL NORMALISED RATIO INCREASED 102 0.0036
598 BRONCHOSPASM 51 0.0036
599 RETCHING 76 0.0036
600 NERVOUS SYSTEM DISORDER 111 0.0036
601 VISUAL ACUITY REDUCED 118 0.0035
602 BRADYCARDIA 188 0.0035
603 HYPOTHYROIDISM 113 0.0035
604 ABDOMINAL PAIN 823 0.0035
605 URINARY RETENTION 118 0.0035
606 CONSTIPATION 769 0.0035
607 HYPERCHOLESTEROLAEMIA 34 0.0035
608 FAECES DISCOLOURED 76 0.0035
609 PREMATURE BABY 105 0.0035
610 HEPATIC FUNCTION ABNORMAL 130 0.0035
611 CHILLS 408 0.0035
612 NIGHT SWEATS 112 0.0035
613 INTESTINAL PERFORATION 39 0.0035
614 DECREASED APPETITE 805 0.0035
615 HYPOTHERMIA 35 0.0035
616 RASH ERYTHEMATOUS 165 0.0034
617 GINGIVAL BLEEDING 47 0.0034
618 DRUG INEFFECTIVE 4515 0.0034
619 SWOLLEN TONGUE 106 0.0034
620 PHOTOSENSITIVITY REACTION 56 0.0034
621 LOCALISED INFECTION 82 0.0034
622 RESTLESSNESS 124 0.0034
623 INTERVERTEBRAL DISC PROTRUSION 74 0.0034
624 LOCAL SWELLING 59 0.0034
625 HYPERTENSION 715 0.0034
626 ISCHAEMIC STROKE 60 0.0034
627 ANKLE FRACTURE 52 0.0034
628 SWELLING 314 0.0034
629 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 78 0.0033
630 EPISTAXIS 250 0.0033
631 OFF LABEL USE 2925 0.0033
632 DIARRHOEA 2156 0.0033
633 MYOCARDIAL ISCHAEMIA 38 0.0033
634 FOOT DEFORMITY 37 0.0033
635 NEPHROLITHIASIS 153 0.0033
636 MICTURITION URGENCY 38 0.0033
637 LUNG DISORDER 163 0.0033
638 CHROMATURIA 75 0.0033
639 IMPAIRED HEALING 109 0.0033
640 DEPRESSED LEVEL OF CONSCIOUSNESS 131 0.0033
641 THROMBOSIS 266 0.0033
642 WHITE BLOOD CELL COUNT DECREASED 356 0.0033
643 EYE INFECTION 37 0.0033
644 MACULAR DEGENERATION 39 0.0033
645 SCIATICA 52 0.0033
646 ANOREXIA 42 0.0033
647 PARAESTHESIA ORAL 47 0.0033
648 NASAL CONGESTION 191 0.0032
649 MUSCULAR WEAKNESS 368 0.0032
650 PULMONARY FIBROSIS 62 0.0032
651 SINUS DISORDER 64 0.0032
652 WEIGHT DECREASED 897 0.0032
653 DRY MOUTH 260 0.0032
654 BEDRIDDEN 42 0.0032
655 SPINAL FRACTURE 64 0.0032
656 EATING DISORDER 68 0.0032
657 MYOCLONUS 38 0.0032
658 CYANOSIS 50 0.0032
659 THROAT IRRITATION 142 0.0032
660 DYSPNOEA 1782 0.0031
661 NODULE 41 0.0031
662 CEREBRAL HAEMORRHAGE 112 0.0031
663 BLOOD TRIGLYCERIDES INCREASED 55 0.0031
664 MYELODYSPLASTIC SYNDROME 45 0.0031
665 SKIN HAEMORRHAGE 46 0.0031
666 ARRHYTHMIA 146 0.0031
667 ACUTE HEPATIC FAILURE 42 0.0031
668 TREATMENT NONCOMPLIANCE 168 0.0031
669 PANCREATITIS 162 0.0031
670 DERMATITIS 64 0.0031
671 SKIN REACTION 43 0.0030
672 NAUSEA 2407 0.0030
673 SWELLING FACE 198 0.0030
674 CORONARY ARTERY DISEASE 92 0.0030
675 IRRITABLE BOWEL SYNDROME 65 0.0030
676 MUSCULOSKELETAL DISCOMFORT 52 0.0030
677 GASTROINTESTINAL DISORDER 270 0.0030
678 APHONIA 42 0.0030
679 ABDOMINAL DISTENSION 314 0.0030
680 DIABETES MELLITUS 229 0.0030
681 SKIN DISORDER 100 0.0030
682 DIABETIC KETOACIDOSIS 72 0.0030
683 HIP FRACTURE 96 0.0030
684 BACK PAIN 693 0.0030
685 RENAL DISORDER 138 0.0030
686 RECTAL HAEMORRHAGE 127 0.0030
687 DYSARTHRIA 111 0.0029
688 APHASIA 89 0.0029
689 METASTASES TO LUNG 34 0.0029
690 MUSCLE SPASTICITY 36 0.0029
691 CONFUSIONAL STATE 472 0.0029
692 CONTUSION 281 0.0029
693 LYMPHOMA 45 0.0029
694 MELAENA 64 0.0029
695 PERITONITIS 60 0.0029
696 PLASMA CELL MYELOMA 113 0.0029
697 LUNG NEOPLASM MALIGNANT 119 0.0029
698 CARDIO-RESPIRATORY ARREST 121 0.0029
699 TOOTH EXTRACTION 36 0.0029
700 LIVER INJURY 71 0.0029
701 ULCER 46 0.0029
702 FLUID RETENTION 147 0.0029
703 INFUSION RELATED REACTION 191 0.0029
704 FULL BLOOD COUNT DECREASED 58 0.0029
705 DYSPEPSIA 282 0.0029
706 FIBROMYALGIA 69 0.0028
707 FEAR 76 0.0028
708 HEPATOCELLULAR INJURY 40 0.0028
709 BLOOD PRESSURE SYSTOLIC INCREASED 55 0.0028
710 CYST 35 0.0028
711 ANXIETY 791 0.0028
712 INTENTIONAL PRODUCT USE ISSUE 243 0.0028
713 ASTHENIA 1043 0.0028
714 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 133 0.0028
715 HEPATIC CIRRHOSIS 52 0.0028
716 PULMONARY ARTERIAL HYPERTENSION 40 0.0028
717 POLLAKIURIA 115 0.0028
718 THERAPY PARTIAL RESPONDER 43 0.0028
719 WOUND 77 0.0028
720 LIVER DISORDER 122 0.0027
721 RASH MACULAR 96 0.0027
722 CHEST DISCOMFORT 280 0.0027
723 INTESTINAL OBSTRUCTION 103 0.0027
724 HYPOGLYCAEMIA 132 0.0027
725 SKIN FISSURES 53 0.0027
726 PHOTOPHOBIA 51 0.0027
727 CHEST PAIN 500 0.0027
728 HALLUCINATION 203 0.0027
729 GALLBLADDER DISORDER 48 0.0027
730 LIMB INJURY 73 0.0027
731 HYPERSOMNIA 77 0.0027
732 PALLOR 73 0.0027
733 FALL 891 0.0027
734 TYPE 2 DIABETES MELLITUS 90 0.0027
735 SYNCOPE 267 0.0027
736 JOINT STIFFNESS 70 0.0027
737 CHOKING 52 0.0027
738 THYROID DISORDER 41 0.0027
739 MALIGNANT NEOPLASM PROGRESSION 272 0.0027
740 HEAD INJURY 84 0.0027
741 HEART RATE INCREASED 261 0.0026
742 COVID-19 462 0.0026
743 METASTASES TO BONE 43 0.0026
744 ECZEMA 137 0.0026
745 FATIGUE 2033 0.0026
746 RASH 1138 0.0026
747 PERIPHERAL SWELLING 401 0.0026
748 CATARACT 155 0.0026
749 MUSCULOSKELETAL PAIN 136 0.0026
750 NECK PAIN 145 0.0026
751 CARDIAC FAILURE 208 0.0026
752 INJURY 182 0.0026
753 ACUTE MYOCARDIAL INFARCTION 76 0.0026
754 OSTEONECROSIS 84 0.0026
755 MULTIPLE FRACTURES 42 0.0026
756 RHINORRHOEA 165 0.0026
757 BLOOD PRESSURE DECREASED 169 0.0025
758 SKIN EXFOLIATION 214 0.0025
759 TREMOR 421 0.0025
760 SEIZURE 292 0.0025
761 GAIT DISTURBANCE 482 0.0025
762 INFLUENZA 278 0.0025
763 JOINT INJURY 53 0.0025
764 ARTHRITIS 195 0.0025
765 ANGINA PECTORIS 71 0.0025
766 DISABILITY 49 0.0025
767 THROAT TIGHTNESS 67 0.0025
768 NEOPLASM PROGRESSION 86 0.0025
769 DYSSTASIA 72 0.0025
770 BLOOD PRESSURE INCREASED 377 0.0025
771 PRODUCT USE ISSUE 463 0.0025
772 HAEMORRHAGE 257 0.0025
773 MUSCLE SPASMS 451 0.0025
774 GLYCOSYLATED HAEMOGLOBIN INCREASED 62 0.0025
775 RASH PAPULAR 55 0.0025
776 METASTASES TO LIVER 43 0.0024
777 LOWER LIMB FRACTURE 47 0.0024
778 DRUG INTOLERANCE 236 0.0024
779 DEPRESSION 555 0.0024
780 FACE OEDEMA 41 0.0024
781 BALANCE DISORDER 210 0.0024
782 PAIN IN EXTREMITY 711 0.0024
783 HYPOKINESIA 35 0.0024
784 INSOMNIA 640 0.0024
785 EOSINOPHILIA 42 0.0024
786 INTERSTITIAL LUNG DISEASE 116 0.0024
787 EMOTIONAL DISTRESS 290 0.0024
788 HYPOAESTHESIA ORAL 36 0.0024
789 FLATULENCE 135 0.0024
790 TOOTH LOSS 49 0.0024
791 WEIGHT INCREASED 528 0.0024
792 RASH GENERALISED 61 0.0024
793 AGITATION 173 0.0024
794 DYSGEUSIA 174 0.0023
795 TRANSIENT ISCHAEMIC ATTACK 79 0.0023
796 HYPOAESTHESIA 350 0.0023
797 SCAR 40 0.0023
798 EPILEPSY 71 0.0023
799 DRUG ERUPTION 41 0.0023
800 BLOOD COUNT ABNORMAL 35 0.0023
801 PAIN 1412 0.0023
802 ABDOMINAL PAIN LOWER 58 0.0023
803 HAEMATOCHEZIA 126 0.0023
804 DISORIENTATION 90 0.0023
805 LABORATORY TEST ABNORMAL 67 0.0023
806 COGNITIVE DISORDER 106 0.0023
807 COLD SWEAT 40 0.0023
808 SLEEP DISORDER 160 0.0023
809 BLOOD URINE PRESENT 43 0.0023
810 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 161 0.0023
811 DEAFNESS 59 0.0023
812 ILLNESS 232 0.0022
813 BONE PAIN 131 0.0022
814 VERTIGO 136 0.0022
815 HYPERSENSITIVITY 413 0.0022
816 SKIN DISCOLOURATION 102 0.0022
817 ALTERED STATE OF CONSCIOUSNESS 48 0.0022
818 COLITIS ULCERATIVE 99 0.0022
819 RASH PRURITIC 120 0.0022
820 JOINT SWELLING 267 0.0022
821 DIABETES MELLITUS INADEQUATE CONTROL 39 0.0022
822 GAIT INABILITY 73 0.0022
823 ERYTHEMA 449 0.0022
824 FREQUENT BOWEL MOVEMENTS 59 0.0022
825 BURNING SENSATION 153 0.0022
826 GLAUCOMA 42 0.0022
827 ACTIVITIES OF DAILY LIVING IMPAIRED 43 0.0022
828 BONE DENSITY DECREASED 68 0.0022
829 BLOOD CHOLESTEROL INCREASED 101 0.0022
830 DRY EYE 108 0.0022
831 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 55 0.0021
832 NASOPHARYNGITIS 394 0.0021
833 ANAPHYLACTIC REACTION 118 0.0021
834 CONVULSION 122 0.0021
835 ARTHRALGIA 887 0.0021
836 THERAPEUTIC RESPONSE DECREASED 129 0.0021
837 PSORIATIC ARTHROPATHY 86 0.0021
838 BLOOD PRESSURE ABNORMAL 42 0.0021
839 INTENTIONAL DOSE OMISSION 60 0.0021
840 POOR QUALITY SLEEP 45 0.0021
841 APPLICATION SITE PAIN 46 0.0021
842 MIGRAINE 199 0.0021
843 HEART RATE IRREGULAR 47 0.0021
844 RESPIRATORY ARREST 57 0.0021
845 DYSKINESIA 84 0.0021
846 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 35 0.0021
847 PROCEDURAL PAIN 57 0.0021
848 VISION BLURRED 282 0.0021
849 MALAISE 900 0.0021
850 SYNOVITIS 37 0.0020
851 HEART RATE DECREASED 72 0.0020
852 AGEUSIA 51 0.0020
853 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 35 0.0020
854 HEADACHE 1274 0.0020
855 PARANOIA 35 0.0020
856 THIRST 36 0.0020
857 LACTIC ACIDOSIS 65 0.0020
858 LIMB DISCOMFORT 62 0.0020
859 MYALGIA 340 0.0020
860 COMA 95 0.0020
861 LACRIMATION INCREASED 60 0.0020
862 ABDOMINAL PAIN UPPER 408 0.0020
863 SOMNOLENCE 399 0.0020
864 PRURITUS 757 0.0020
865 DIPLOPIA 51 0.0020
866 MOBILITY DECREASED 141 0.0020
867 FRACTURE 37 0.0020
868 LOSS OF CONSCIOUSNESS 248 0.0019
869 SPEECH DISORDER 101 0.0019
870 ANGIOEDEMA 85 0.0019
871 PARAESTHESIA 302 0.0019
872 SYSTEMIC LUPUS ERYTHEMATOSUS 68 0.0019
873 TARDIVE DYSKINESIA 54 0.0019
874 ANAPHYLACTIC SHOCK 49 0.0019
875 DIZZINESS 946 0.0019
876 ABDOMINAL DISCOMFORT 318 0.0019
877 MUSCULOSKELETAL STIFFNESS 165 0.0019
878 MIDDLE INSOMNIA 35 0.0019
879 SKIN CANCER 40 0.0019
880 MOOD SWINGS 59 0.0018
881 HOT FLUSH 139 0.0018
882 ILL-DEFINED DISORDER 112 0.0018
883 PRODUCT DOSE OMISSION IN ERROR 52 0.0018
884 MEMORY IMPAIRMENT 250 0.0018
885 DISCOMFORT 111 0.0018
886 ROAD TRAFFIC ACCIDENT 76 0.0018
887 BLINDNESS 74 0.0018
888 DEATH 1564 0.0018
889 UPPER LIMB FRACTURE 36 0.0018
890 PRESCRIBED UNDERDOSE 36 0.0018
891 EXPOSURE DURING PREGNANCY 112 0.0018
892 EYE DISORDER 59 0.0018
893 PALPITATIONS 209 0.0018
894 FOETAL EXPOSURE DURING PREGNANCY 145 0.0018
895 ALOPECIA 350 0.0018
896 HOSPITALISATION 273 0.0018
897 TOXICITY TO VARIOUS AGENTS 298 0.0018
898 THERAPEUTIC RESPONSE UNEXPECTED 79 0.0018
899 FEELING COLD 49 0.0018
900 EMOTIONAL DISORDER 54 0.0017
901 SURGERY 102 0.0017
902 VISUAL IMPAIRMENT 213 0.0017
903 SEDATION 45 0.0017
904 IRRITABILITY 103 0.0017
905 FEMUR FRACTURE 53 0.0017
906 DEMENTIA 47 0.0017
907 CEREBROVASCULAR ACCIDENT 283 0.0017
908 MYELOSUPPRESSION 60 0.0017
909 HYPERHIDROSIS 212 0.0016
910 INFLUENZA LIKE ILLNESS 135 0.0016
911 UNEVALUABLE EVENT 123 0.0016
912 ARTHROPATHY 90 0.0016
913 URTICARIA 269 0.0016
914 AMNESIA 104 0.0016
915 FEELING HOT 98 0.0016
916 BLOOD CREATINE PHOSPHOKINASE INCREASED 46 0.0016
917 EYE SWELLING 59 0.0016
918 RHABDOMYOLYSIS 66 0.0016
919 SNEEZING 35 0.0016
920 BLOOD GLUCOSE INCREASED 292 0.0015
921 PRODUCT DOSE OMISSION ISSUE 454 0.0015
922 ABASIA 38 0.0015
923 THERAPY INTERRUPTED 109 0.0015
924 OCULAR HYPERAEMIA 72 0.0015
925 MEDICATION ERROR 84 0.0015
926 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 272 0.0015
927 PSORIASIS 197 0.0015
928 CARDIAC DISORDER 141 0.0015
929 DRY SKIN 200 0.0015
930 DEPRESSED MOOD 79 0.0015
931 MENTAL DISORDER 65 0.0015
932 ABNORMAL BEHAVIOUR 59 0.0015
933 HYPOACUSIS 64 0.0015
934 GASTRIC DISORDER 51 0.0015
935 ACCIDENTAL OVERDOSE 54 0.0015
936 MUSCLE TWITCHING 34 0.0015
937 FLUSHING 149 0.0015
938 MOVEMENT DISORDER 47 0.0015
939 MENTAL IMPAIRMENT 35 0.0014
940 CARDIOVASCULAR DISORDER 36 0.0014
941 TINNITUS 65 0.0014
942 FEELING ABNORMAL 338 0.0014
943 MATERNAL EXPOSURE DURING PREGNANCY 125 0.0014
944 BLOOD GLUCOSE DECREASED 67 0.0014
945 MYOCARDIAL INFARCTION 243 0.0014
946 PRODUCT DOSE OMISSION 90 0.0014
947 NEOPLASM MALIGNANT 91 0.0014
948 ADVERSE DRUG REACTION 120 0.0013
949 ANGER 45 0.0013
950 EYE IRRITATION 76 0.0013
951 EYE PRURITUS 43 0.0013
952 DRUG ADMINISTRATION ERROR 39 0.0013
953 NERVOUSNESS 66 0.0013
954 PAIN OF SKIN 34 0.0013
955 PANIC ATTACK 46 0.0013
956 THERAPY CESSATION 63 0.0012
957 MULTIPLE SCLEROSIS 54 0.0011
958 VAGINAL HAEMORRHAGE 49 0.0011
959 CRYING 39 0.0011
960 DISTURBANCE IN ATTENTION 57 0.0011
961 DRUG EFFECT INCOMPLETE 38 0.0010
962 RHEUMATOID ARTHRITIS 118 0.0010
963 ADVERSE EVENT 92 0.0010
964 AGGRESSION 48 0.0010
965 SUICIDAL IDEATION 86 0.0009
966 INTENTIONAL PRODUCT MISUSE 82 0.0009
967 DRUG DOSE OMISSION 151 0.0009
968 WITHDRAWAL SYNDROME 38 0.0009
969 OVERDOSE 194 0.0009
970 DRUG EFFECT DECREASED 48 0.0009
971 UNDERDOSE 65 0.0009
972 MULTIPLE SCLEROSIS RELAPSE 61 0.0009
973 INJECTION SITE BRUISING 71 0.0009
974 INCORRECT DOSE ADMINISTERED 196 0.0009
975 THERAPEUTIC PRODUCT EFFECT DECREASED 36 0.0008
976 ACNE 60 0.0008
977 INJECTION SITE REACTION 54 0.0008
978 DERMATITIS ATOPIC 41 0.0008
979 PRODUCT QUALITY ISSUE 100 0.0007
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 137 0.0007
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 47 0.0007
982 INJECTION SITE PRURITUS 42 0.0006
983 NO ADVERSE EVENT 109 0.0006
984 INJECTION SITE SWELLING 46 0.0006
985 INJECTION SITE PAIN 179 0.0006
986 INJECTION SITE ERYTHEMA 71 0.0006
987 DEVICE ISSUE 50 0.0006
988 DEVICE MALFUNCTION 37 0.0005
989 SKIN BURNING SENSATION 36 0.0005
990 PRODUCT STORAGE ERROR 42 0.0005
991 ACCIDENTAL EXPOSURE TO PRODUCT 37 0.0004
992 DRUG DEPENDENCE 43 0.0003